Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-11-15 Wang Xiaodong Director Sale −395 $202.05 $80K 0
2019-11-15 Wu Xiaobin President & GM China Sale −1,000 $202.05 $202K 0
2019-11-14 Wang Xiaodong Director Sale −800 $191.03 $153K 9,200
2019-11-14 Wang Xiaodong Director Sale −2,500 $192.19 $480K 6,700
2019-11-14 Wang Xiaodong Director Sale −2,200 $193.04 $425K 4,500
2019-11-14 Wang Xiaodong Director Sale −704 $194.12 $137K 3,796
2019-11-14 Wang Xiaodong Director Sale −1,900 $195.14 $371K 1,896
2019-11-14 Wang Xiaodong Director Sale −300 $195.86 $59K 1,596
2019-11-14 Wang Xiaodong Director Sale −100 $196.87 $20K 1,496
2019-11-14 Wang Xiaodong Director Sale −2,605 $193.57 $504K 395
2019-11-13 Wang Xiaodong Director Other disposition −50 4,903,998
2019-11-13 Wang Xiaodong Director Grant or award +50 50
2019-11-05 Chen Timothy Yung-Cheng Director Option exercise +4,000 $41.01 $164K 4,000
2019-11-05 Chen Timothy Yung-Cheng Director Sale −200 $187.38 $37K 3,800
2019-11-05 Chen Timothy Yung-Cheng Director Sale −1,500 $188.71 $283K 2,300
2019-11-05 Chen Timothy Yung-Cheng Director Sale −1,892 $189.56 $359K 408
2019-11-05 Chen Timothy Yung-Cheng Director Sale −208 $190.32 $40K 200
2019-11-05 Chen Timothy Yung-Cheng Director Option exercise · Share Option (Right to Buy) +52,000 65,988
2019-11-04 Huang Jane CMO, Hematology Option exercise +32,900 $29.49 $970K 32,900
2019-11-04 Huang Jane CMO, Hematology Sale −4,569 $189.08 $864K 28,331

Page 98 of 99 · 1,972 trades